Dr. Javier Salgado Pogacnik, MD

Dr. Salgado Pogacnik practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Salgado Pogacnik's NPI, 1043647290, was assigned on October 2, 2013. Dr. Salgado Pogacnik graduated from Universidad Nacional de Cordoba in 2004. Dr. Salgado Pogacnik holds Texas license S1700.

Dr. Salgado Pogacnik's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Salgado Pogacnik's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Salgado Pogacnik is also affiliated with Parkland Memorial Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Salgado Pogacnik to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salgado Pogacnik practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Salgado Pogacnik's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Salgado Pogacnik is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Salgado Pogacnik's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Salgado Pogacnik treats.

CMS data shows 201 Medicare services from Dr. Salgado Pogacnik across 5 procedure codes in 2024, for 153 Medicare patients. Medicare paid $23,620 for them.

CMS counts 153 Medicare patients who saw Dr. Salgado Pogacnik in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salgado Pogacnik's median patient age at 57, with 47% women.

In 2024, Dr. Salgado Pogacnik wrote 171 Medicare Part D claims for 70 patients. 97% of them were for generic drugs. CMS names the drug for 119 of them, across 5 drugs with 11 or more claims each, at $1,133 in total drug cost. In 2023, CMS named 109 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Salgado Pogacnik for performance year 2024, reported as part of a group. Dr. Salgado Pogacnik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salgado Pogacnik as offering telehealth. CMS counts 11 procedures of colonoscopy by Dr. Salgado Pogacnik, more than 41% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Salgado Pogacnik, published from 2019 to 2023. Dr. Salgado Pogacnik's most frequent co-authors are Georgios Karagkounis, MD, Patricio Marcelo Polanco, MD and Anupama N. Wadhwa, MD.

Dr. Salgado Pogacnik graduated from Universidad Nacional de Cordoba in 2004.

Dr. Salgado Pogacnik is in network with 22 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.